M
Malcolm W. Greaves
Researcher at St Thomas' Hospital
Publications - 213
Citations - 13528
Malcolm W. Greaves is an academic researcher from St Thomas' Hospital. The author has contributed to research in topics: Histamine & Human skin. The author has an hindex of 60, co-authored 213 publications receiving 13054 citations. Previous affiliations of Malcolm W. Greaves include National University of Malaysia & St. John's University.
Papers
More filters
Journal ArticleDOI
Autoantibodies against the High-Affinity IgE Receptor as a Cause of Histamine Release in Chronic Urticaria
Michihiro Hide,D.M. Francis,Clive Grattan,John Hakimi,Jarema Peter Kochan,Malcolm W. Greaves +5 more
TL;DR: Histamine-releasing IgG autoantibodies against the alpha subunit of the high-affinity IgE receptor are present in the circulation of some patients with chronic urticaria.
Journal ArticleDOI
Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report.
Marcus Maurer,Karsten Weller,Carsten Bindslev-Jensen,Ana Giménez-Arnau,P. J. Bousquet,Jean Bousquet,G.W. Canonica,M. K. Church,M. K. Church,Kiran Godse,Clive Grattan,Malcolm W. Greaves,Michihiro Hide,Dimitris Kalogeromitros,Allen P. Kaplan,Sarbjit S. Saini,X J Zhu,T. Zuberbier +17 more
TL;DR: A GA2LEN task force report concluded that chronic spontaneous urticaria is a “hidden epidemic” that needs to be addressed to address the unmet clinical needs of patients.
Journal ArticleDOI
The impact of chronic urticaria on the quality of life
TL;DR: The patients with DPU had significantly more problems with mobility, gardening and choice of clothing than the uncomplicated CU patients, and suffered more pain, had more issues with work and were more restricted in their hobbies.
Journal ArticleDOI
Treatment of psoriasis.
TL;DR: Psoriasis is a chronic, genetically influenced, remitting and relapsing scaly and inflammatory skin disorder that affects 1 to 3 percent of the world's population and has a social and economic impact that is underestimated by physicians and other health care providers.
Journal ArticleDOI
EAACI/GA2LEN/EDF guideline: management of urticaria
T. Zuberbier,Carsten Bindslev-Jensen,Walter Canonica,Clive Grattan,Malcolm W. Greaves,Beate M. Henz,Alexander Kapp,M. M. A. Kozel,Marcus Maurer,Hans F. Merk,T. Schafer,Dagmar Simon,Gino A. Vena,Bettina Wedi +13 more
TL;DR: The recommended first line treatment are nonsedating H1 antihistamines, but dosages increased up to fourfold over the recommended doses may be necessary for different urticaria subtypes and in view of individual variation in the course of the disease and response to treatment.